DRUG NAME: Warfarin
DRUG CLASS: Vitamin K Antagonist

MECHANISM OF ACTION:
- Primary: Inhibits vitamin K epoxide reductase, preventing activation of clotting factors II, VII, IX, X
- Bleeding: Impairs coagulation cascade leading to prolonged clotting times

COMMON ADVERSE EFFECTS:
- bleeding
- bruising
- hemorrhage
- hematoma

SERIOUS ADVERSE EFFECTS:
- major hemorrhage
- intracranial bleeding
- warfarin necrosis
- purple toe syndrome

RISK FACTORS:
- elderly
- falls risk
- concurrent antiplatelet agents
- liver disease
- malignancy
- poor INR control

MONITORING:
- INR
- signs of bleeding

